| Product Code: ETC7638608 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Prophylactic Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Ireland Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Ireland Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Ireland Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Ireland Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Ireland Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Ireland Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Ireland Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on preventive healthcare in Ireland |
4.2.2 Rising awareness about vaccination benefits and importance |
4.2.3 Growing government initiatives to promote immunization |
4.3 Market Restraints |
4.3.1 High costs associated with vaccine development and production |
4.3.2 Concerns about vaccine safety and side effects |
5 Ireland Prophylactic Vaccines Market Trends |
6 Ireland Prophylactic Vaccines Market, By Types |
6.1 Ireland Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Ireland Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Ireland Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Ireland Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Ireland Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Ireland Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Ireland Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Ireland Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Ireland Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Ireland Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Ireland Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Ireland Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Ireland Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Ireland Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Ireland Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Ireland Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Ireland Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Ireland Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Ireland Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Ireland Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Ireland Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Ireland Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Ireland Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Ireland Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Ireland Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Ireland Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Prophylactic Vaccines Market Export to Major Countries |
7.2 Ireland Prophylactic Vaccines Market Imports from Major Countries |
8 Ireland Prophylactic Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates in Ireland |
8.2 Research and development investments in prophylactic vaccines |
8.3 Adoption rates of new vaccines in the market |
9 Ireland Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Ireland Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Ireland Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Ireland Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Ireland Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Ireland Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Ireland Prophylactic Vaccines Market - Competitive Landscape |
10.1 Ireland Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here